Search

everythinglearnresearchcommunity

for

Search:↓

Rezpegaldesleukin shows promise for treating severe alopecia areata.

Tigason improved hair growth in a boy with monilethrix without side effects.

Brentuximab may cause hair to regain color.

Baricitinib effectively promotes regrowth of eyebrows and eyelashes in alopecia areata patients.

The treatment was not recommended due to limited effectiveness and significant side effects.

50-mg ritlecitinib capsules are bioequivalent to 100-mg capsules.

The drug combination was safe and showed promise in treating advanced tumors.

New compounds called benzoquinolinones may treat conditions linked to excess DHT.

Tofacitinib partially improved hair regrowth in a patient with severe hair loss.

A new treatment for hair loss shows promise with fewer side effects.

Bicalutamide may improve hair growth in postmenopausal women with mild side effects.

CB-03-04 shows promise as a treatment for prostate issues due to its strong anti-androgen effects.

Ritlecitinib and baricitinib are similarly effective for hair regrowth in severe alopecia areata.

Oxyresveratrol promotes hair growth and may help treat hair loss.

SADBE treatment led to complete hair regrowth in mice with alopecia areata by altering immune cell movement.

Upadacitinib effectively improved severe atopic dermatitis and alopecia universalis in a 29-year-old man.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

Dutasteride may help shrink prostate cancer tumors.

Vemurafenib causes significant skin side effects, requiring regular dermatologist care and sun protection.

A new topical treatment for hair loss shows strong hair growth effects with low toxicity.

Imatinib can repigment grey hair, while SU11428 can cause temporary hair depigmentation.

Bimekizumab effectively treated a man's chronic beard hair loss.

Baricitinib improves quality of life and reduces anxiety and depression in severe alopecia areata patients with hair regrowth.

Inhibiting retinoic acid activates WNT signaling, potentially aiding hair disorder and skin cancer treatments.

An extract from Quercus acutissima bark was found to reduce sebum production and block an enzyme linked to acne.

Low-dose sorafenib can cause severe facial acne, treatable with topical medication.